Hinova Pharmaceuticals, Inc. Class ASSE: 688302

Report for Q3 2024

Oct 26, 2024 · Issued by Hinova Pharmaceuticals, Inc. Class A via Shanghai Stock Exchange

Report for Q3 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment